Dear Media Friends, We Cordially Invite You To the Press Show of the movie тАШGood DayтАЩStarring – Prithiviraj Ramalingam, Kaali Venkat, Myna Nandhini, Bose Venkat, Bhagavathi Perumal, Aadukalam Murugadoss, Vela Ramamurthy and OthersProduced By Prithiviraj RamalingamDirected By AravindhanDate : 23.06.2025 (Monday, Tomorrow)Time : 3 PMLocation : Prasad Lab, Saligramam Thanks & Regards Team Good Day Team AIM
7:10 pm
Monday
Gentle Reminder :Dear Media Friends, We Cordially Invite You To the Press Show of the movie тАШGood DayтАЩStarring – Prithiviraj Ramalingam, Kaali Venkat, Myna Nandhini, Bose Venkat, Bhagavathi Perumal, Aadukalam Murugadoss, Vela Ramamurthy and OthersProduced By Prithiviraj RamalingamDirected By AravindhanDate : 23.06.2025 (Monday, Today)Time : 3 PMLocation : Prasad Lab, Saligramam Thanks & Regards Team Good Day Team AIM
AKB Developers & Promoters, a trusted name in ChennaiтАЩs real estate landscape, celebrates over 36 years of delivering legally clear, high-quality residential developments. Established in 1991, the company has become a symbol of reliability and customer trust in the cityтАЩs growing property market.
A first-generation enterprise now guided by its second generation, AKB has successfully sold over 1.5 million square feet across the Chennai region. With offerings ranging from apartments and villas to premium plotted developments, AKB caters to a broad segment of homebuyers, with prices ranging between тВ╣20 lakhs and тВ╣1 crore. With the launch of its 93rd project, AKB Developers & Promoters continues its mission to provide properties with transparent documentation and uncompromised development standards. Each project is carefully planned to meet the evolving needs of ChennaiтАЩs urban homebuyers, with a strong emphasis on infrastructure, connectivity, and value appreciation.
тАЬWe believe that trust is built over time, and every square foot weтАЩve developed in Chennai reflects that belief,тАЭ says the companyтАЩs leadership. тАЬOur goal is not just to sell property, but to deliver a secure future for families through responsible development.тАЭ
With a deep understanding of ChennaiтАЩs real estate dynamics and a forward-thinking vision, AKB Developers & Promoters remains committed to shaping communities that last. As the company expands its footprint, it continues to set benchmarks in quality, customer service, and ethical business practices.
For Chennai homebuyers, AKB remains a name synonymous with trust, transparency, and long-term value.
Press Release 20th June 2025: Meril Life Sciences, a leading global med-tech company, marked a significant milestone with the launch of MyClip, IndiaтАЩs first Transcatheter Edge-To-Edge Repair (TEER) system, on June 14. The landmark Structural Heart Innovation event, held at Meril Academy, Vapi (Gujarat) from June 13тАУ15, brought together over 150 Indian interventional cardiologists along with cardiac imaging expert and international stalwarts, including Prof. Ottavio Alfieri (тАЬFather of mitral valve repairтАЭ), Prof. Francesco Maisano, and Prof. Agricola, joining global pioneers in edge-to-edge mitral valve repair.
Meril is currently the worldтАЩs leading TAVI group following the success of Myval THV and first Indian company to introduce a TEER system, placing the country firmly on the map as an innovator in transcatheter heart valve therapies (with both replacement and repair technology platforms). MyClip introduction demonstrates IndiaтАЩs growing capabilities in structural heart solutions and reflects MerilтАЩs commitment to accessible cutting-edge cardiac care.
MyClip TEER System is designed for patients suffering from severe Mitral Regurgitation (MR) who are at high surgical risk due to pre-existing issues like hypertension, diabetes, obesity, advanced age, physical frailty, enlarged or weak heart, and patients with kidney, lung and liver problems. MR, particularly if untreated, has a devastating mortality rateтАФover 50% of patients may not survive without timely intervention, and 1-year mortality can be as high as 57%.
The MyClip TEER System enables precise closure of the mitral valve flaps, effectively preventing the backward flow of purified blood into the lungs. The procedure is minimally invasive, & takes approximately one hour, and allows patients to return home within 3тАУ5 days. After discharge, patients can resume daily activities like walking and non-strenuous work within a short period post the procedure.
According to the landmark COAPT Study published in the New England Journal of Medicine (NEJM), patients receiving device-based therapy for mitral regurgitation experienced significantly better outcomes compared to those receiving standard medical treatment. Within 24 months, the hospitalization rate for heart failure was reduced to 35.8% per patient-year in the device group, compared to 67.9% in the control group. Additionally, mortality within the same period was notably lower in the device group, at 29.1%, compared to 46.1% in the control group.
Currently, approximately 150 TEER (Transcatheter Edge-to-Edge Repair) procedures are performed annually in India, with the majority of patients falling in the younger age group (30 тАУ 60). These statistics bring to light a pressing need for early and effective intervention in younger demographics.
The launch of MyClip TEER System marks a transformative moment for structural heart therapy in India. Transcatheter Edge-to-Edge Repair (TEER) therapy has shown significant success over traditional Guideline Directed Medical Therapy (GDMT). MyClip represents a major step forward in India’s cardiovascular treatment landscape.
In his inaugural speech, Sanjeev Bhatt, Senior Vice President of Corporate Strategy at Meril Life Sciences, said, тАЬIn India, around 1.5 million people are known to have severe mitral regurgitation. Of these at least 1.2 million are post myocardial infarction (MI or a heart attack) or due to heart failure. Introduction of the MyClip TEER system marks a pivotal shift and weтАЩre witnessing early adoption. MerilтАЩs efforts in training cardiologists and building TEE-based imaging expertise are crucial steps in scaling this life-saving therapy across the country.”
тАЬWith MyClip, Meril is reshaping the countryтАЩs role in global medtech. This homegrown innovation is a testament to what Indian science, engineering, and clinical collaboration can achieve together. MerilтАЩs nationwide public awareness campaign #TreatmentZarooriHai is in full swing, with brand ambassador MS Dhoni, to educate patients and families about the life-saving value of timely intervention in mitral valve regurgitation,тАЭ Mr. Bhatt added.
The two-day Structural Heart Innovation scientific program featured case demonstrations, interactive hands-on workshops, and the presentations leading Interventional Cardiologists and Echocardiologists. The event concluded with a call to build a sustainable M-TEER ecosystem in India, focused on accessibility, clinical excellence, and continuous innovation.
With multiple New Routes, NueGo Expands Its Green Footprint Across North, South, and Central India
Chennai, June 23, 2025: NueGo, India’s leading premium electric intercity bus brand from GreenCell Mobility, has achieved a significant milestone by expanding its network to electric intercity routes across the country. This expansion reinforces its commitment to providing sustainable and zero-emission mobility, offering passengers a greener, smarter, and more comfortable alternative to conventional bus travel. The launch aimed at improving regional connectivity includes the introduction of new routes covering the length and breadth of the country.
NueGo is dedicated to connecting major cities and regions with its 300+ fleet of 100% electric and zero-emission buses. The brand’s focus remains on offering a safe, timely, and comfortable journey for all guests. As part of its growth strategy and expanding horizons in the Indian market, NueGo has introduced multiple new routes to serve the growing passenger demand for eco-conscious, comfortable, and reliable intercity travel options. The launch of its newest and longest electric intercity bus route, connecting Delhi to Lucknow, covering this extensive route in approximately 10 hours, this milestone marks a significant leap in sustainable travel, setting a new benchmark for long-distance EV intercity transportation in India. More newly introduced routes include services connecting Amritsar to Delhi, Bengaluru to Davanagere, Harihar, and Madurai, Chennai to Madurai and Salem, Delhi to Bareilly, Haldwani, and Sirsa, Guntur to Visakhapatnam, and Gurugram to Haldwani, Jaipur-Kota, Delhi-Hisar, Amritsar-Jammu, Indore-Ratlam, Hyderabad-Kurnool, and Bangalore-Mysore.
Speaking on the expansion, Mr. Devndra Chawla, Managing Director and Chief Executive Officer, GreenCell Mobility, said, тАЬAt NueGo, we are constantly working to create a network that is as sustainable as it is comfortable. With these new routes, weтАЩre enabling more travellers to choose a greener alternative without compromising on safety or quality. This is not just about expansionтАФitтАЩs about leading a nationwide movement for zero-emission intercity transport.тАЭ
Key Highlights: –
New Routes тАУ new daily routes now connecting major cities, including Delhi-Lucknow (The City of Nawabs), Delhi-Amritsar (Home of the Golden Temple) , Delhi-Bareilly (Land of Jhumkas and culture), Bengaluru- Madurai (The Temple City of South India), Chennai- Salem (Steel City of Tamil Nadu), and moreтАж.
India’s First Electric Sleeper Buses тАУ NueGo, the first brand to launch India’s first fully electric AC sleeper bus service
Cutting-Edge Fleet тАУ state-of-the-art electric buses with fast-charging technology, 500+ km range per charge and premium passenger amenities
Smart Travel Experience тАУ AI-powered booking, real-time tracking, and onboard Wi-Fi for seamless journeys
Setting a new benchmark for long-distance EV intercity transportation in India
NueGo prioritizes the safety & comfort of its passengers and is the first brand to equip its entire electric bus fleet with Advanced Driver Assistance Systems (ADAS). NueGo has been a frontrunner in championing WomenтАЩs Safety in IndiaтАЩs intercity electric bus service sector. It is the first brand to launch a dedicated 24×7 helpline number for women travellers, introduce Pink Seat feature while ticket booking, providing clean and hygienic mid-points and buses equipped with advanced cutting-edge security measures such as CCTV Surveillance, GPS Live Tracking, DriverтАЩs Breath Analyzer Tests, Speed lock at 80 km/hr and more.
NueGo has strategically enhanced its operational efficiency with the establishment of over 50 mid-points nationwide, equipped with cutting-edge charging infrastructure to ensure a smooth travel experience for all passengers. By operating a 100% electric fleet, NueGo contributes to reducing carbon emissions and promoting a greener future for intercity travel.
Chennai, June 22, 2025: CTS Speciality Hospital, a trusted name in orthopedic care in Chennai, has introduced robot-assisted total knee replacement procedures at its Anna Nagar facility, becoming the only hospital in the area to offer this cutting-edge technology known for ensuring surgical precision, minimising risks, and promoting quicker, safer recovery.
The robotic system, developed by the US-based VELYS a leader in orthopedic robotics was officially launched by Mr. M. K. Mohan, MLA of Anna Nagar , in the presence of Dr. Prakash Selvam, Chairman, and Dr. Radhika Venugopal, Managing Director of CTS Speciality Hospital.
CTS Speciality Hospital is a 35-bed facility dedicated to advanced orthopedic care, led by Dr. Prakash Selvam, a seasoned orthopedic surgeon with over 20 years of clinical and surgical experience. Reputed for joint replacement and complex orthopedic procedures, the hospital has a multidisciplinary team of experts in joint replacement, arthroscopy, trauma care, sports injuries, and rehabilitation.
In his comments on the launch of robot-assisted procedure, Dr. Prakash Selvam said, тАЬWe are proud to introduce the future of orthopedic care to the people in this region with the launch of the VELYS robotic-assisted solution. While traditional knee replacement surgeries are effective, they often rely heavily on the surgeonтАЩs skill and can vary in outcome. Robot-assisted technology enhances precision by using advanced mapping and real-time data to tailor each procedure to the patientтАЩs unique knee anatomy. This results in more accurate implant placement, reduced tissue damage, minimal blood loss, and faster recovery. Patients benefit from improved joint alignment, greater stability, reduced pain, and better long-term mobility with a shorter hospital stay. Our strengths lie not only in surgical precision, but also in thorough pre-operative planning, personalised recovery programs, and long-term joint health management.тАЭ
CTS will not be limiting the robot-assisted surgery only to knee replacementsтАФit will apply the technology to other orthopedic procedures, particularly hip replacements and partial joint reconstructions. тАЬThe enhanced precision of robotic systems allows for optimal implant positioning and alignment, which is critical not only in total knee arthroplasty but also in complex hip surgeries, including total hip replacements and revisions. Looking ahead, we are planning to expand robotic applications to include procedures such as unicompartmental (partial) knee replacements, shoulder arthroplasty, and even spine surgeries, based on patient suitability and future technological advancements,тАЭ he added.
On the significance of the surgeonтАЩs expertise in robot-assisted surgery, Dr. Prakash Selvam said, тАЬWhile robot-assisted technology enhances precision and consistency in knee surgeries, human expertise remains absolutely essential for successful outcomes. Robots are valuable toolsтАФthey assist with preoperative planning, ensure accurate bone cuts, and help align implants with sub-millimeter accuracy. However, it is the surgeon who makes critical decisions in real time, guided by the patientтАЩs anatomy, joint condition, and overall health. Every patient presents unique challenges that demand clinical judgment, adaptability, and experienceтАФqualities no machine can replicate. From selecting the appropriate implant to managing unexpected intraoperative findings, it is the surgeonтАЩs skill that ensures the technology delivers its full potential.тАЭ